NEA Management Company, LLC
Top Portfolio Positions
25 positions ·
$1,745,893,804 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
3,045,262 | $349,656,982 | 20.03% | |
| CELC |
Celcuity Inc.
Healthcare
|
2,285,561 | $260,873,932 | 14.94% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
7,392,301 | $191,534,518 | 10.97% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
13,222,228 | $157,741,180 | 9.03% | |
| SVRA |
Savara Inc
Healthcare
|
24,471,264 | $133,613,101 | 7.65% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
7,692,298 | $126,538,302 | 7.25% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,614,486 | $107,892,407 | 6.18% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
4,023,219 | $78,653,931 | 4.51% | |
| COUR |
Coursera, Inc.
Consumer Defensive
|
12,867,769 | $74,890,415 | 4.29% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
3,969,834 | $58,832,939 | 3.37% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SYBX
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3,273,504 | 2,922,772 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,875,183 | 2,922,772 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,711,920 | 2,922,772 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,624,237 | 2,922,772 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,091,880 | 2,922,772 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,354,930 | 2,922,772 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,384,158 | 2,922,772 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,231,761 | 2,922,772 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,252,679 | 2,922,774 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $792,220 | 281,929 | Shares | Defined | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||